DoseMe and Keegan Mason & Associates Announce Collaboration to Advance Clinical Outcomes and Antimicrobial Stewardship in Rural and Community Hospitals
In this article:
Jupiter, FL and Rapid City, SD – August 21, 2025
DoseMe, a leading provider of model-informed precision dosing (MIPD) software, and Keegan Mason & Associates (KMA), a respected consulting firm specializing in infectious disease and healthcare quality improvement, are pleased to announce a new collaborating partnership aimed at advancing antimicrobial stewardship and improving clinical outcomes for hospitals, especially those serving rural and underserved communities.
This collaboration brings together KMA’s extensive clinical leadership and hands-on hospital support experience with DoseMe’s precision dosing technology, empowering lean clinical teams to optimize therapy in real-time, even in the most resource-constrained settings.
“We’re proud to partner with Keegan Mason & Associates, who share our mission of democratizing access to quality care,” said Dr. Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer at DoseMe. “Their deep expertise in infectious disease and stewardship, paired with DoseMeRx’s automation and ease of use, allows even the smallest hospitals to deliver individualized, evidence-based care.”
Dr. James Michael Keegan, KMA principal partner and infectious disease physician with over 35 years of experience, has been a national leader in the fight against antibiotic resistance. His stewardship programs have consistently reduced overuse of broad-spectrum antibiotics, mitigated Clostridoides difficile infections, and improved patient outcomes in a wide range of hospital and care setting environments.
Randee Mason, RN, BSN, CPHQ, KMA principal partner and certified healthcare quality expert, adds deep experience leading multi-hospital collaborations and statewide initiatives in patient safety and antimicrobial stewardship.
“At KMA, we are committed to delivering innovative, sustainable solutions to hospitals no matter their size or location,” said Mason. “DoseMeRx’s precision dosing platform supports that goal by streamlining workflows and arming clinicians with actionable data, helping us drive better outcomes where it matters most.”
Supporting Stewardship Where It’s Needed Most
With deployments already supporting hospitals in South Dakota, West Virginia, and other rural markets, the partnership is particularly focused on helping lean teams optimize antimicrobial use without the burden of complex data analysis and protocol decisions.
DoseMeRx’s platform automates pharmacokinetic modeling, allowing for real-time, patient-specific dosing recommendations for medications such as vancomycin and aminoglycosides, agents that are central to many stewardship efforts. Through this partnership, hospitals working with KMA will gain enhanced clinical guidance and protocol support to effectively maximize DoseMeRx’s decision-support tools.
About DoseMe
DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPPA complaint and is the only Bayesian dosing platform to be HITRUST CSF R2 certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories
About Keegan Mason & Associates (KMA)
KMA is a consulting firm founded by Dr. James M. Keegan and Randee Mason, RN, dedicated to improving clinical quality and patient safety across healthcare systems. With deep expertise in infectious disease, antimicrobial stewardship, epidemiology, and Lean quality improvement, KMA supports hospitals nationwide with customized, actionable strategies to improve care, especially in rural and underserved regions.